American Cancer Society Cancer Action Network (Acscan)

ACS CAN is the nonprofit, nonpartisan advocacy affiliate of the American Cancer Society

Based in DC

🤖

AI Overview

With $2.5M in lobbying spend across 34 quarterly filings, American Cancer Society Cancer Action Network (Acscan) is a significant lobbying presence. They deploy 12 individual lobbyists Their lobbying covers 3 issue areas. Active from 2018 to 2025.

$2.5M
Total Spend
8
Years Active
1
Firms Hired
12
Lobbyists Deployed
3
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2018$320K
2019$320K
2020$250K
2021$300K
2022$400K
2023$320K
2024$320K
2025$320K

Issues Lobbied

Lobbying Firms

Lobbyists

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Budget/Appropriations, Health Issues, Medicare/Medicaid

  • H.R. 1625 - Consolidated Appropriations Act of 2018
  • H.R. 1892 - Bipartisan Budget Act of 2018
  • Cervical Cancer Screening, colorectal screening
  • H.R. 1676/S. 693 - Palliative Care and Hospice Education and Training Act
  • S. 870 - Chronic Care
  • H.R. 2430 - FDA Reauthorization Act of 2017
  • Affordable C
  • Part B reimbursement
  • cancer screening
  • Part B reimbursement, Part D forumulary issues, prescription drug access & affordability
  • cancer screening
  • opioids
  • H.R. 1625 - Consolidated Appropriations Act of 2018
  • H.R. 1892 - Bipartisan Budget Act of 2018
  • 2019 Appropriations

Related Analysis

Related Investigations

Similar Clients

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.